"Our clinical trials bring hope to others inflicted with the same health conditions that better prevention, diagnosis, and treatment are on the edge of discovery. • ​Free access to new treatments that are not yet offered on the market • Medically guided care under close supervision of a medical doctor and team • Medically guided care under close supervision of a medical doctor and team Participation in clinical trials is at NO COST to patients and no insurance is required, you may be compensated for your time & travel"

During the past decade, Synergy Group US LLC conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Synergy Group US LLC" #1 sponsor was "George Medicines PTY Limited" with 2 trials, followed by "CyMedica Orthopedics, Inc" with 1 trials sponsored, "ModernaTX, Inc." with 1 trials sponsored, "Phathom Pharmaceuticals, Inc." with 1 trials sponsored and "Regeneron Pharmaceuticals" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Synergy Group US LLC" are "Hypertension" (2 trials), "Cytomegalovirus Infection" (1 trials), "Heartburn" (1 trials), "Knee Osteoarthritis" (1 trials) and "Non-Erosive Gastro-Esophageal Reflux Disease" (1 trials). Many other conditions were trialed in "Synergy Group US LLC" in a lesser frequency.

Most popular intervention types in "Synergy Group US LLC" are "Drug" (3 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg" (2 trials), "Amlodipine 2.5 mg/indapamide 1.25 mg" (1 trials), "Home-based Neuromuscular Electrical Stimulation (NMES) therapy" (1 trials) and "No Intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Synergy Group US LLC" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Synergy Group US LLC". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Synergy Group US LLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Synergy Group US LLC, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".